£15.0M
Vita Spring provided the funding as QuantuMDx also pursues commercialisation discussions with Sansure Biotech.
QuantuMDx
QuantuMDx builds rapid point of care PCR diagnostic devices.
£15.0MTotal raised
QuantuMDx develops molecular point of care diagnostic solutions designed to empower disease control and pathogen identification. The company operates globally with strategic partnerships across multiple continents.
Categories
Team
JO
Jonathan O’Halloran
Chief Executive
FS
Fiona Smith
VP Marketing